Arrowhead Pharmaceuticals Inc (ARWR) — Free Cash Flow Generation Index

Latest as of September 2025: 0.63x

Arrowhead Pharmaceuticals Inc (ARWR) has a Free Cash Flow Generation Index of 0.63x as of September 2025. Free cash flow of $13.00 Million represents 1% of operating cash flow ($20.49 Million). Explore ARWR capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.63x
Free Cash Flow / Operating CF

Free Cash Flow

$13.00 Million
USD

Operating Cash Flow

$20.49 Million
USD

Capital Expenditures

$7.49 Million
USD

Arrowhead Pharmaceuticals Inc Free Cash Flow Generation Index (1997–2025)

Historical FCF Generation Index trend for Arrowhead Pharmaceuticals Inc across 4 annual periods. For the full cash flow conversion analysis, see ARWR cash generation efficiency.

Annual Free Cash Flow Generation for Arrowhead Pharmaceuticals Inc (1997–2025)

Year-by-year Free Cash Flow Generation Index for Arrowhead Pharmaceuticals Inc. Check Arrowhead Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.87x $156.89 Million $179.55 Million $22.67 Million ▲ +1.3%
2021 0.86x $147.66 Million $171.22 Million $23.57 Million ▼ -7.3%
2019 0.93x $161.03 Million $173.03 Million $12.00 Million ▼ -6.9%
1997 1.00x $4.56K $4.56K $0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).